CI Quote, Financials, Valuation and Earnings

CVS Health has a net margin of 2.17% compared to The Cigna Group's net margin of 1.68%. The Cigna Group's return on equity of 8.07% beat CVS Health's return on equity of 6.12%.

The Cigna Group has a consensus price target of $362.55, signalling upside risk potential of 15.52%. On the other hand CVS Health has an analysts' consensus of $72.46 which suggests that it could grow by 7.14%. Given that The Cigna Group has higher upside potential than CVS Health, analysts believe The Cigna Group is more attractive than CVS Health.

The Cigna Group has a beta of 0.506, which suggesting that the stock is 49.385% less volatile than S&P 500. In comparison CVS Health has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.622%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.82%. CVS Health offers a yield of 3.93% to investors and pays a quarterly dividend of $0.67 per share. The Cigna Group pays 45.63% of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.7B, which are smaller than CVS Health quarterly revenues of $97.7B. The Cigna Group's net income of $1.4B is lower than CVS Health's net income of $1.6B. Notably, The Cigna Group's price-to-earnings ratio is 25.64x while CVS Health's PE ratio is 18.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.36x versus 0.23x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 2.17% compared to The Cigna Group's net margin of 0.92%. The Cigna Group's return on equity of 8.07% beat Elevance Health's return on equity of 14.4%.

The Cigna Group has a consensus price target of $362.55, signalling upside risk potential of 15.52%. On the other hand Elevance Health has an analysts' consensus of $498.97 which suggests that it could grow by 15.8%. Given that Elevance Health has higher upside potential than The Cigna Group, analysts believe Elevance Health is more attractive than The Cigna Group.

The Cigna Group has a beta of 0.506, which suggesting that the stock is 49.385% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.773, suggesting its less volatile than the S&P 500 by 22.685%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.82%. Elevance Health offers a yield of 1.53% to investors and pays a quarterly dividend of $1.71 per share. The Cigna Group pays 45.63% of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.7B, which are larger than Elevance Health quarterly revenues of $45.4B. The Cigna Group's net income of $1.4B is higher than Elevance Health's net income of $418M. Notably, The Cigna Group's price-to-earnings ratio is 25.64x while Elevance Health's PE ratio is 16.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.36x versus 0.57x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 2.17% compared to The Cigna Group's net margin of 2.39%. The Cigna Group's return on equity of 8.07% beat Molina Healthcare's return on equity of 25.84%.

The Cigna Group has a consensus price target of $362.55, signalling upside risk potential of 15.52%. On the other hand Molina Healthcare has an analysts' consensus of $338.46 which suggests that it could grow by 2.36%. Given that The Cigna Group has higher upside potential than Molina Healthcare, analysts believe The Cigna Group is more attractive than Molina Healthcare.

The Cigna Group has a beta of 0.506, which suggesting that the stock is 49.385% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.701, suggesting its less volatile than the S&P 500 by 29.866%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.82%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cigna Group pays 45.63% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.7B, which are larger than Molina Healthcare quarterly revenues of $10.5B. The Cigna Group's net income of $1.4B is higher than Molina Healthcare's net income of $251M. Notably, The Cigna Group's price-to-earnings ratio is 25.64x while Molina Healthcare's PE ratio is 16.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.36x versus 0.47x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 2.17% compared to The Cigna Group's net margin of 5.5%. The Cigna Group's return on equity of 8.07% beat UnitedHealth Group's return on equity of 14.34%.

The Cigna Group has a consensus price target of $362.55, signalling upside risk potential of 15.52%. On the other hand UnitedHealth Group has an analysts' consensus of $629.92 which suggests that it could grow by 13.72%. Given that The Cigna Group has higher upside potential than UnitedHealth Group, analysts believe The Cigna Group is more attractive than UnitedHealth Group.

The Cigna Group has a beta of 0.506, which suggesting that the stock is 49.385% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.293%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.82%. UnitedHealth Group offers a yield of 1.52% to investors and pays a quarterly dividend of $2.10 per share. The Cigna Group pays 45.63% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.7B, which are smaller than UnitedHealth Group quarterly revenues of $100.8B. The Cigna Group's net income of $1.4B is lower than UnitedHealth Group's net income of $5.5B. Notably, The Cigna Group's price-to-earnings ratio is 25.64x while UnitedHealth Group's PE ratio is 35.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.36x versus 1.28x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.